eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR
US Market
Holding EFTR?
Track your performance easily

eFFECTOR Therapeutics (EFTR) Technical Analysis

261 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
eFFECTOR Therapeutics’s (EFTR) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting eFFECTOR Therapeutics is a Sell.
eFFECTOR Therapeutics’s (EFTR) 20-Day exponential moving average is 0.05, while eFFECTOR Therapeutics’s (EFTR) share price is <$0.1, making it a Sell.
eFFECTOR Therapeutics’s (EFTR) 50-Day exponential moving average is 0.30, while eFFECTOR Therapeutics’s (EFTR) share price is <$0.1, making it a Sell.

eFFECTOR Therapeutics (EFTR) Pivot Points

Sep 20, 2024, 09:33 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.03
0.04
0.04
0.05
0.05
0.06
0.06
Fibonacci
0.04
0.04
0.04
0.05
0.05
0.05
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

eFFECTOR Therapeutics (EFTR) Moving Averages

Sep 20, 2024, 09:33 AM
Period
Simple
Exponential
MA5
0.04Sell
0.04Sell
MA10
0.04Sell
0.04Sell
MA20
0.04Sell
0.05Sell
MA50
0.05Sell
0.30Sell
MA100
0.72Sell
1.66Sell
MA200
5.56Sell
5.53Sell
eFFECTOR Therapeutics’s (EFTR) 10-Day exponential moving average is 0.04, while eFFECTOR Therapeutics’s (EFTR) share price is <$0.1, making it a Sell.
eFFECTOR Therapeutics’s (EFTR) 100-Day exponential moving average is 1.66, while eFFECTOR Therapeutics’s (EFTR) share price is <$0.1, making it a Sell.
eFFECTOR Therapeutics’s (EFTR) stock price is <$0.1 and eFFECTOR Therapeutics’s (EFTR) 50-day simple moving average is 0.05, creating a Sell signal.
eFFECTOR Therapeutics’s (EFTR) stock price is <$0.1 and eFFECTOR Therapeutics’s (EFTR) 100-day simple moving average is 0.72, creating a Sell signal.
eFFECTOR Therapeutics’s (EFTR) stock price is <$0.1 and eFFECTOR Therapeutics’s (EFTR) 200-day simple moving average is 5.56, creating a Sell signal.

eFFECTOR Therapeutics (EFTR) Technical Indicators

Sep 20, 2024, 09:33 AM
Name
Value
Implied Action
RSI (14)
35.99
Neutral
STOCH (9,6)
33.33
Neutral
STOCHRSI (14)
44.44
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
35.80
Neutral
Williams %R
-66.67
Buy
CCI (14)
-12.79
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
28.84
Sell
ROC
0.00
-
eFFECTOR Therapeutics’s (EFTR) Relative Strength Index (RSI) is 35.99, creating a Neutral signal.
eFFECTOR Therapeutics’s (EFTR) Trend Strength Indicator (ADX) is 35.80, creating a Neutral signal.
eFFECTOR Therapeutics’s (EFTR) Commodity Channel Index (CCI) is -12.79, creating a Neutral signal.

FAQ

Is EFTR a Buy, Hold, or Sell?
Based on EFTR’s technical indicators, EFTR is a Strong Sell.
    What is EFTR’s RSI (14)?
    EFTR’s RSI (14) is 35.99, which suggests EFTR is a Neutral.
      What is EFTR’s MACD?
      EFTR’s MACD is -0.02, which suggests EFTR is a Sell.
        What is EFTR’s 5-day moving average?
        EFTR’s 5-day moving average is 0.04, which suggests EFTR is a Sell.
          What is EFTR’s 20-day moving average?
          EFTR 20-day moving average is 0.04, which suggests EFTR is a Sell.
            What is EFTR’s 50-day moving average?
            EFTR’s 50-day moving average is 0.05, which suggests EFTR is a Sell.
              What is EFTR’s 200-day moving average?
              EFTR’s 200-day moving average is 5.56, which suggests EFTR is a Sell.
                What is EFTR’s Williams % R (14)?
                EFTR’s Williams % R (14) is -66.67, which suggests EFTR is a Buy.
                  What is EFTR’s CCI (14)?
                  EFTR’s CCI (14) is -12.79, which suggests EFTR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis